News Summary: Pfizer 2Q net income jumps 25 pct

Associated Press
FILE- In this Thursday, July 12, 2012, file photo, Centrum multivitamins are shown on the packaging line at the Pfizer plant in Montreal.  Pfizer Inc.'s second-quarter net income jumped 25 percent as sharply lower costs for production, marketing and restructuring more than offset a plunge in revenue from cholesterol fighter Lipitor caused by generic competition. The Viagra maker said Tuesday, July 31, 2012,  that net income was $3.25 billion, or 43 cents per share, up from $2.61 billion, or 33 cents per share, a year earlier. (AP Photo/The Canadian Press, Graham Hughes, File)

View gallery

BOUNCING BACK: Pfizer overcame the expected sales plunge from worsening generic competition to cholesterol blockbuster Lipitor, thanks to lower charges and reduced spending on production, research and administration.

THE NUMBERS: Net income jumped 25 percent to $3.25 billion, or 43 cents per share. Adjusted earnings were $4.67 billion, or 62 cents per share — 8 cents higher than expected. Revenue fell 9 percent to $15.06 billion.

COMING UP: Pfizer expects to sell its nutrition business for $11.85 billion by 2013's first half, and to register by mid-August for a potential IPO of up to 20 percent of its animal health business.

Sorry you didn't like this comment. Please provide a reason below.

Are you sure?
Rating failed. Try again.
Request failed. Try again.
We will promote constructive and witty comments to the top, so everyone sees them!
Sorry, we can’t load comments right now. Try again.

    Recommended for You